Abstract
Hepatocyte apoptosis contributes to liver injury and fibrosis after cholestatic injury. Our aim was to ascertain if the anti-apoptotic protein Mcl-1 alters liver injury or fibrosis in the bile duct-ligated mouse. Markers of apoptosis and fibrosis were compared in wild-type and transgenic mice expressing human Mcl-1 after bile duct ligation. Compared to hMcl-1 transgenic animals, ligated wild-type mice displayed a significant increase in TUNEL-positive cells and in caspase 3/7-positive hepatocytes. Consistent with apoptotic injury, the pro-apoptotic protein Bak underwent a conformational change to an activated form upon cholestatic injury, a change mitigated by hMcl-1 overexpression. Likewise, liver histology, number of bile infarcts, serum ALT values, markers of hepatic fibrosis, and animal survival were improved in bile duct-ligated mice transgenic for hMcl-1 as compared to wild-type mice. In conclusion, increased Mcl-1 expression plays a role in hepatoprotection upon cholestatic liver injury.
Original language | English (US) |
---|---|
Pages (from-to) | 1908-1917 |
Number of pages | 10 |
Journal | Digestive diseases and sciences |
Volume | 54 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2009 |
Keywords
- Apoptosis
- Bile infarct
- Liver fibrosis
- Stellate cells
ASJC Scopus subject areas
- Physiology
- Gastroenterology